Work

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

Year: 2016

Type: erratum

Source: Journal of Hematology & Oncology

DOI: 10.1186/s13045-016-0364-0

Authors: George S. Laszlo, Todd A. Alonzo, Chelsea J. Gudgeon, Kimberly H. Harrington, Alex Kentsis, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Soheil Meshinchi, Roland B. Walter

Institutions: Fred Hutch Cancer Center, University of Southern California, Children's Oncology Group, Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine, St. Jude Children's Research Hospital, University of Minnesota, Masonic Cancer Center, Children's Mercy Hospital, University of Washington

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,990

Funder: National Cancer Institute

Award: Children's Oncology Group Statistics and Data Center

OpenAlex ID: W4250229165

Cites: 1

Cited by: 7

Related to: 10